Skip to content
Dose Brief
Menu
No. 129 here · Grade C

GoodRx review

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

Visit GoodRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
Not disclosed
Tirzepatide
From $299/mo (brand Zepbound)
Coverage
All 50 states
Brand-name
Yes

Prices read from GoodRx's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $299/mo (brand Zepbound) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

GoodRx scored on our six Brief Score factors. See the methodology.

Price Stability58/100
Supply Reliability77/100
Transparency68/100
Access Breadth86/100
Clinical Oversight68/100
Track Record84/100

What we like

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

The caveats

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

The brief

Best for: Readers who want self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

Ranked #129 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about GoodRx.

Closest here

The providers scoring nearest GoodRx — the realistic shortlist if you're weighing it.

Weighing GoodRx against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs GoodRx, and every provider that outranks it is listed on the GoodRx alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect GoodRx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on GoodRx's site. Not medical advice; see our disclosure.

← Back to all rankings